SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

Search

Orion Oyj (Class B)

مغلق

57.05 1.87

نظرة عامة

تغير سعر السهم

24 ساعة

الحالي

الحد الأدنى

56.1

الحد الأقصى

57.15

المقاييس الرئيسية

By Trading Economics

الدخل

-12M

61M

المبيعات

-80M

355M

نسبة السعر إلى الأرباح (P/E)

متوسط القطاع

21.996

56.602

ربحية السهم (EPS)

0.44

عائد التوزيعات

2.99

هامش الربح

17.287

الموظفين

3,943

الأرباح قبل الفوائد والضرائب والإهلاك والاستهلاك (EBITDA)

136M

202M

توزيعات الأرباح

By Dow Jones

عائد التوزيعات

متوسط القطاع

2.99%

2.45%

احصائيات السوق

By TradingEconomics

القيمة السوقية

2.1B

7.7B

الافتتاح السابق

55.18

الإغلاق السابق

57.05

Orion Oyj (Class B) الرسم البياني

فالأداء السابق ليس مؤشرًا موثوقًا به للنتائج المستقبلية.

الأخبار ذات الصلة

15 مايو 2025، 10:52 م UTC

الأرباح
المحركون الرئيسيون في السوق

Virgin Galactic Shares Rise on Commercial Spaceflight Plans, Narrower 1Q Loss

15 مايو 2025، 08:37 م UTC

أهم الأخبار
الأرباح

Applied Materials Logs Higher 2Q Profit, Revenue as Customer Demand Remains Unchanged

16 مايو 2025، 12:00 ص UTC

حديث السوق

Xero Bull Stays Positive on Cost Outlook -- Market Talk

15 مايو 2025، 11:47 م UTC

حديث السوق

Gold Consolidates; Likely Supported by Signs of Disinflation -- Market Talk

15 مايو 2025، 11:38 م UTC

حديث السوق

Global Forex and Fixed Income Roundup: Market Talk

15 مايو 2025، 11:38 م UTC

حديث السوق

Nikkei May Edge Higher, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 مايو 2025، 11:14 م UTC

أهم الأخبار

Walmart Becomes Biggest Retailer Yet to Pass Through Tariff Price Increases -- 4th Update

15 مايو 2025، 10:46 م UTC

أهم الأخبار
عمليات الاستحواذ والاندماج والاستيلاء

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15 مايو 2025، 10:46 م UTC

عمليات الاستحواذ والاندماج والاستيلاء

Bayer Working With Restructuring Advisers Latham, AlixPartners to Explore Options for Monsanto -- WSJ

15 مايو 2025، 10:46 م UTC

عمليات الاستحواذ والاندماج والاستيلاء

Bayer Exec Says Company Committed to Resolving Roundup Lawsuits in 18 Months -- WSJ

15 مايو 2025، 10:46 م UTC

عمليات الاستحواذ والاندماج والاستيلاء

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15 مايو 2025، 09:58 م UTC

الأرباح

Applied Materials Earnings Beat Expectations. Why the Stock Is Down. -- Barrons.com

15 مايو 2025، 09:24 م UTC

الأرباح

Cava's Earnings Beat Expectations. Growth Was Strong Despite Tariff Fears. -- Barrons.com

15 مايو 2025، 08:56 م UTC

حديث السوق

U.S. Spending Downturn Could Lie Ahead -- Market Talk

15 مايو 2025، 08:54 م UTC

حديث السوق
الأرباح

Applied Materials CFO Says Demand Stable Despite Tariffs, Macro -- Market Talk

15 مايو 2025، 08:54 م UTC

الأرباح

Applied Materials Investing to Support Semiconductor Market of More Than $1T by End of Decade, Financial Chief Says

15 مايو 2025، 08:51 م UTC

الأرباح

Applied Materials Financial Chief: Long-Term Secular Growth Drivers Remain Intact

15 مايو 2025، 08:50 م UTC

حديث السوق

Financial Services Roundup: Market Talk

15 مايو 2025، 08:50 م UTC

عمليات الاستحواذ والاندماج والاستيلاء

Berkshire Sells Financial Stocks, Doubles Constellation Stake, Holds Steady on Apple -- WSJ

15 مايو 2025، 08:50 م UTC

الأرباح

Applied Materials' Customer Investments Continue at Expected Rate and Pace, Financial Chief Says

15 مايو 2025، 08:47 م UTC

الأرباح

Applied Materials Not Currently Seeing Large Changes in Customer Demand, CEO Says

15 مايو 2025، 08:47 م UTC

الأرباح

Applied Materials Sees Revenue From Advanced DRAM Customers to Grow 40% in FY25, CEO Says

15 مايو 2025، 08:47 م UTC

الأرباح

Applied Materials Grew Faster Than Peers in Markets Outside China in 2Q, CEO Says

15 مايو 2025، 08:47 م UTC

الأرباح

Applied Materials Underperformed Market in China in 2Q Due to Restrictions on U.S. Companies, CEO Says

15 مايو 2025، 08:37 م UTC

الأرباح

SOS Ltd: Growth Was Fueled by Robust Domestic Demand and Expansion of Pdt Portfolio to Include Rubber and Coal >SOS

15 مايو 2025، 08:37 م UTC

الأرباح

SOS Ltd: Cryptocurrency Mining Rev Declined to $9.3M From $18.9M in FY23, Dip Was Attributed to the Temporary Shutdown of Texas Mining Facility for Upgrades During 1H 2024 >SOS

15 مايو 2025، 08:37 م UTC

الأرباح

SOS Ltd: FY24 Significant Yr-over-Yr Increase in Commodity Trading Rev, Which Soared to $214.3M FY24, 92.6% of Total Rev Up From 74.0% in FY23 >SOS

15 مايو 2025، 08:37 م UTC

الأرباح

SOS Ltd: Cryptocurrency Mining Rev Halves as SOS Focuses on Facility Upgrades and Commodity Expansion >SOS

15 مايو 2025، 08:26 م UTC

أهم الأخبار

Trump Presses Apple to Bring iPhone Manufacturing to America. Wall Street Shrugs. -- WSJ

15 مايو 2025، 08:25 م UTC

الأرباح

Deere Stock Jumps on Guidance Cut. Here's Why. -- Barrons.com

مقارنة الأقران

تغير السعر

Orion Oyj (Class B) التوقعات

الماليات

مصروفات البيع والإدارة

مصروفات التشغيل

الربح قبل الضرائب

المبيعات

تكلفة المبيعات

الربح الإجمالي على المبيعات

حساب الفائدة على الديون

الأرباح قبل الفوائد والضرائب والإهلاك والاستهلاك (EBITDA)

ربح التشغيل

$

نبذة عن Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.